trending Market Intelligence /marketintelligence/en/news-insights/trending/akg3tswxxw5ctvbjblzwyq2 content esgSubNav
In This List

Coherus BioSciences appoints former Anthem exec to board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Coherus BioSciences appoints former Anthem exec to board

Coherus Biosciences Inc. appointed Samuel Nussbaum to its board of directors.

The appointee is the former vice president of clinical health policy and chief medical officer of Anthem Inc., having served in those roles from 2000 to 2016.

The Redwood City, Calif.-based company said Nussbaum's appointment will help with Coherus' efforts to introduce its biosimilar medicines in the market.